# **Williams Syndrome Foundation**
## **FINANCIAL STATEMENTS**
for the year ended
**31 March 2023**
**Williams Syndrome Foundation**
## **CONTENTS**
||Page|
|---|---|
|Legal and administrative information|1|
|Report of the Trustees|3|
|Report of the Independent Examiner|7|
|Statement of financial activities|9|
|Balance sheet|10|
|Notes to the financial statements|12|
**Williams Syndrome Foundation YEAR ENDED 31 March 2023 LEGAL AND ADMINISTRATIVE INFORMATION**
|**CHARITY REGISTRATION NO.**|281014 (ENG & WALES); SC049897 (SCOTLAND)|
|---|---|
|**COMPANY REGISTRATION NO.**|1523794|
|**PATRONS**|Mr Peter Davison, Ms Elizabeth Morton & Mr Tim Cooper|
|**TRUSTEES AND DIRECTORS**|M J Burrows|
||P R Lawrie (Chairman)|
||J R Folliss (Treasurer)|
||J C Lovell (Resigned 02/11/2022)|
||M J Adlam|
||L Fisk|
||N D T Martin|
||P Taylor|
||S J Spencer (Appointed 01/02/2023)|
||B Vasey (Appointed 08/06/2022)|
||M J Wolfman (Appointed 01/02/2023)|
|**SECRETARY**|J C Lovell (Resigned 02/11/2022)|
||E H Martin (Appointed 02/11/2022)|
|**CHIEF EXECUTIVE**|E H Martin|
|**REGISTERED OFFICE**|North House|
||198 High Street|
||Tonbridge|
||Kent TN9 1BE|
|**PROFESSIONAL ADVISORY PANEL**|Dr N Martin MD BSc MRCP|
||Professor J Atkinson PhD|
||Dr J Davies BSc BDS MFDSRCS(Eng)|
||Professor P Howlin MSc PhD CPsychol FBPsS|
||Dr R Johnson BM MRCP|
||Dr K Metcalfe MBBCh FRCP MD|
||Dr R Padidela MRCPCH MD DNB|
||Professor D Riby PhD|
||Dr E Sidebotham MBChB (Hons) FRCS MD|
||Dr J Van Herwegen PhD|
||Ms A Hart BSc MSc (OT)|
||Mrs O Sutton|
||Ms M Ambrosio BSc MASLTIP MRCSLT HCPC|
||Professor E Farran PhD|
||Dr F Tynan|
||Mr D Robinson BA FCCA APFS TEP LLAA IMC CFP MSCI|
||Mr B Leach RNMH MNurs|
||Mr C Pemberton TEP|
||Ms Heledd Wyn Solicitor|
Page 1
**Williams Syndrome Foundation YEAR ENDED 31 March 2023 LEGAL AND ADMINISTRATIVE INFORMATION**
**PROFESSIONAL ADVISORY PANEL (continued)** Ms K Mjadzelics Ms J Whale P R Lawrie Mr M J Adlam MBA Mrs E H Martin BSc **BANKERS** CAF Bank Ltd 25 Kings Hill Avenue Kings Hill West Malling Kent ME19 4JQ **INDEPENDENT EXAMINER** A S Healey FCA CTA DChA Lindeyer Francis Ferguson Limited Chartered Accountants North House 198 High Street Tonbridge Kent TN9 1BE **INVESTMENT COMMITTEE** P R Lawrie J R Folliss E H Martin M J Adlam **INVESTMENT ADVISORS** Brewin Dolphin 12 Smithfield London EC1A 9LA
Page 2
**Williams Syndrome Foundation YEAR ENDED 31 March 2023**
## **REPORT OF THE TRUSTEES**
The Trustees, who are also Directors of the Charity for the purposes of the Companies Act, submit their annual report and the audited financial statements for the year ended 31 March 2023.
The Trustees confirm that the report and financial statements of the Charity comply with the current statutory requirements, the requirements of the company's governing document, and the provisions of "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019) (Charities SORP (FRS 102)).
Legal and administrative information set out pages 1-2 forms part of this report.
## **Charity status**
Williams Syndrome Foundation is a Charitable Company limited by guarantee. It was incorporated on 22 October 1980 and is governed by Articles of Association as adopted on 27 July 2022.
## **Governance and internal control**
The Charity is organised so that the Trustees meet regularly to manage its affairs. The Chief Executive manages the affairs of the Charity on a day to day basis with additional assistance as required.
The Board as a whole appoints new Trustees, and one-third of the Trustees retire and are eligible for reappointment, each year. New Trustees are normally parents or relatives of individuals with Williams Syndrome, or have a professional skill required by the Charity. The Trustees are inducted by briefings from the Chief Executive and the Chairman and relevantly skilled Trustee(s).
## **Objectives and activities**
The objectives of the Charity are the provision of support, information and advice on all aspects of Williams Syndrome; supporting and generating research with practical applications that will further increase understanding of Williams Syndrome; to raise awareness of the condition to improve medical, social and educational support and care - for the direct benefit of those who have, or those who support and care for someone with Williams Syndrome - within the UK and elsewhere.
The Aims of the Charity are that:
1. All WS Individuals and carers in the UK have access to the support they need to help address the challenges of the condition.
2. The WSF provides forums in which members and their families can access knowledge, share experience and have fun confidently and safely.
3. The impact of WS on affected individuals, their families and communities is understood as fully as medical and social science enable it to be.
4. There is broad awareness of WS in UK society.
5. The WSF is a commercially sustainable organisation, with processes that are robust, efficient, auditable and compliant with relevant legal and ethical requirements.
Page 3
**Williams Syndrome Foundation YEAR ENDED 31 March 2023 REPORT OF THE TRUSTEES**
6. The WSF is run by dedicated Trustees and employs motivated staff with the necessary skills to perform their duties to best effect.
## **Public benefit**
The Trustees have considered the Charity Commission's guidance on public benefit. Williams Syndrome is a rare disorder, first identified in 1961. The charity’s educational and research activities are considered to be for the benefit of all who have been diagnosed with the condition and those that love, care for and educate them, and thus for public benefit.
## **Review of the year**
WSF staff continue to work with WS individuals of all ages, from infants to those of relative old age, parents, carers, police, hospitals and GP surgeries, multidisciplinary practitioners, educational establishments, housing associations, and supported accommodation providers to support WS people in all areas of their lives.
There have been a few changes to the Board this year as Jon Lovell stepped down as a trustee and company secretary. Liz Martin has since been appointed as company secretary and Bethan Vasey, Stephanie Spencer and Dr Mike Wolfman have joined the board as trustees.
There have been two additions within the Professional Advisory Panel this year with the appointments of Jo Whale (specialist in dyslexia and dyscalculia) and Kirsty Mjadzelics (a mental health nurse).
The Trustees are planning to support a new research project by Professor Emily Farran on motor skills.
The Foundation's ever growing social media presence together with the UK WS Awareness weekend all continue to encourage member approaches and help direct concerned members of the public and professionals to a source of accurate information. We have welcomed 90 new members this year.
The Foundation continues to provide resources, a twice-yearly magazine and monthly member updates, a face-to-face programme of local social and information events, subsidised holidays for its WS adult members and small grants to support family and group holidays and a triennial family gathering and convention. We have held our largest ever weekend National Convention in Bognor Regis for 150 people with WS and their families, which included 17 presentations from 11 professionals, 4 workshops, 2 award ceremonies, 2 discos and 1 concert. We have held 12 online parent support groups and 6 webinars. We have held 98 We Support Friendships Zoom Sessions with adults with WS. We have provided 25 adults with WS with a week’s holiday which allowed 37 parents a week’s respite break. We have held 11 regional events and 10 Christmas Parties. We have published and distributed an Educational Guideline for Learners with WS co-produced by Drs Fionnuala Tynan, Jo Van Herwegen and children with WS.
On-going reporting on the Foundation's activities, events and achievements is shared on our website and social media channels.
Page 4
**Williams Syndrome Foundation YEAR ENDED 31 March 2023**
## **REPORT OF THE TRUSTEES**
Ongoing research covers: WS Sleep Patterns- Dr Dagmara Dimitiriou; RASE WS (Raising Awareness about WS)- Dr Jo Van Herwegen and Professor Janette Atkinson; Parents perception of social inclusion; and the commencement of Social behaviours, Social motivation, and Social Vulnerabilities in Williams Syndrome and Autism - Ellen Ridley and Professor Debbie Riby; Cracking the Pitch Code - Professor Vesna Stojanovik; Embodied Attention and Learning in young children with WS - Professor Hana D'Souza; Mathematical Interventions for Individuals with Williams Syndrome – Dr Jo Van Herwegen and The Importance of Motor Domain on Development in Children with Williams Syndrome – Professor Emily Farran.
## **Financial position**
The Statement of Financial Activities shows a net decrease in resources for the year of £138,765 (2022: surplus of £49,216) after taking into account the loss in the value of the charity's investments during the year as a result of the market performance, which was £32,024. Unrestricted reserves stand at £367,627 at the year end.
Before taking into account the decrease in the value of investments, income was exceeded by expenditure by £106,731 (2022: expenditure exceed income by £32,728). The main item of expenditure during the year was the triennial Weekend Convention and Family Gathering held at Butlin’s Bognor Regis in July at a cost of £117,534.
A substantial part of the income generated during the financial year has, as ever, been from our loyal band of fundraisers to whom we are very grateful.
Many grant making bodies remain closed to us whilst they support charities less financially secure following the covid 19 pandemic, but we continue to look for funding opportunities.
The charity has taken a prudent approach to expenses during the pandemic and reduced rent and office expenses where possible through activities such as increased home working and virtual meetings.
## **Reserves policy**
The charity aims to maintain reserves sufficient to cover a minimum of one year's expenses, and to try to raise enough income to cover current year's expenses. The Trustees believe that this is in the best interests of the Charity.
Most of the employees of WSF have either children or siblings with Williams Syndrome and it is considered vital to ensure that there are sufficient reserves to guarantee continuity of their employment. It is also vital to ensure the key activities and ongoing support can be assured for WS Families.
The charity’s unrestricted reserves as of 31 March 2023 are £367,627. Of this amount £345,640 is represented by fixed asset investments which are invested to raise funds for the charities ongoing benefit, these can be converted to cash within 3 months. This, along with free reserves of £20,993 is adequate to support the planned Medical Research, Regional Activities and the day-to-day expenses of the Charity for the next Financial Year.
The Trustees consider that the financial position of the Charity is stable and satisfactory.
Page 5
**Williams Syndrome Foundation YEAR ENDED 31 March 2023**
## **REPORT OF THE TRUSTEES**
## **Investment policy and objectives**
The charity operates a low-risk attitude towards investment whilst looking for reasonable returns in a challenging economic climate.
## **Statement of directors' and trustees' responsibilities**
The Directors are responsible for preparing financial statements in accordance with applicable law and regulations.
Company law requires the Directors to prepare financial statements for each financial year. Under that law the Directors have elected to prepare financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the Directors are required to:
- select suitable accounting policies and then apply them consistently;
- observe the methods and principles in the Charities SORP;
- make judgments and estimates that are reasonable and prudent;
- state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The Directors are responsible for keeping adequate accounting records sufficient to show and explain the company’s transactions and that disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
This report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime in Part 15 of the Companies Act 2006.
Approved by the Trustees and signed on its behalf by:
**P R Lawrie Trustee**
Date: 6 July 2023
Page 6
**Williams Syndrome Foundation YEAR ENDED 31 March 2023**
## **INDEPENDENT EXAMINER’S REPORT TO THE TRUSTEES OF WILLIAMS SYNDROME FOUNDATION**
I report to the charity trustees on my examination of the financial statements of Williams Syndrome Foundation for the year ended 31 March 2023.
## **Responsibilities and basis of report**
As trustees of the charitable company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Charities and Trustee Investment (Scotland) Act 2005 (‘the 2005 Act’), the Charities Accounts (Scotland) Regulations 2006 (as amended) and the Companies Act 2006.
Having satisfied myself that the financial statements of the charity are not required to be audited under Part 16 of the Companies Act 2006 and are eligible for independent examination, I report in respect of my examination of the charity’s accounts as carried out under section 44 (1) ( c) of the 2005 Act and section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the requirements of Regulation 11 of the Charities Accounts (Scotland) Regulations 2006 (as amended) and the Directions given by the Charity Commission under section 145(5)(b) of the Charities Act 2011.
## **Independent examiner's statement**
Since the charity is required by company law to prepare its accounts on an accruals basis and is registered as a charity in Scotland your examiner must be a member of a body listed in Regulation 11(2) of the Charities Accounts (Scotland) Regulations 2006 (as amended). I can confirm that I am qualified to undertake the examination because I am a registered member of the ICAEW which is one of the listed bodies.
I have completed my examination and I can confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
1. accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act and Regulation 4 of the 2006 Accounts Regulations; or
2. the accounts do not accord with those records with the accounting requirements of Regulation 8 of the Charities Accounts (Scotland) Regulations 2006; or
3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a ‘true and fair view’ which is not a matter considered as part of an independent examination; or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report and in order to enable a proper understanding of the accounts to be reached.
Page 7
**Williams Syndrome Foundation YEAR ENDED 31 March 2023**
## **INDEPENDENT EXAMINER’S REPORT TO THE TRUSTEES OF WILLIAMS SYNDROME FOUNDATION**
**A S Healey FCA CTA DChA Lindeyer Francis Ferguson Limited** Chartered Accountants North House 198 High Street Tonbridge Kent TN9 1BE
Date: 8 August 2023
Page 8
## **WILLIAMS SYNDROME FOUNDATION**
## **STATEMENT OF FINANCIAL ACTIVITIES** _**(INCLUDING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 MARCH 2023**_
|**Note**
**INCOME FROM:**
Donations
**3**
Charitable activities
**4**
Other trading activities
**5**
Investments
**6**
**Total incoming resources**
**EXPENDITURE ON:**
Raising funds
**7**
Charitable activities
**8**
**Total expenditure**
Net (losses)/gains on investments
**13**
**Reconciliation of funds**
Total funds brought forward:
**Total funds carried forward**
**17**
**Net movement in funds**|**_Restricted_**
**_Unrestricted_**
**_funds_**
**_funds_**
**_2023_**
**_2023_**
**_£_**
**_£_**
2,750
119,601
-
43,576
-
10,302
-
11,903
2,750
185,382
-
18,999
2,750
273,114
2,750
292,113
-
( 32,034)
-
( 138,765)
-
506,392
-
367,627|**_Total_**
**_funds_**
**_2023_**
**_£_**
122,351
43,576
10,302
11,903
188,132
18,999
275,864
294,863
( 32,034)
( 138,765)
506,392
367,627|**_Total_**
**_funds_**
**_2022_**
**_£_**
130,793
11,280
6,303
10,136|
|---|---|---|---|
||||158,512|
||||15,574
110,210|
||||125,784|
||||16,488|
||||49,216
457,176|
||||506,392|
Page 9
## **WILLIAMS SYNDROME FOUNDATION**
## **BALANCE SHEET** _**AS AT 31 MARCH 2023**_
|**_Note_**
**Fixed assets**
Tangible assets
**12**
Investments
**13**
**Current assets**
Debtors
**14**
Cash at bank and in hand
**15**
**Net current assets**
**Total net assets**
**The funds of the charity**
Unrestricted funds
**17**
**Total funds**
**Creditors:**amounts falling due after
more than one year|3,910
43,972
47,882
( 26,889)|**_2023_**
**_£_**
994
345,640
346,634
20,993
367,627
367,627
367,627|16,210
131,889
148,099
( 51,978)|**_2022_**
**_£_**
807
409,464|
|---|---|---|---|---|
|||||410,271
96,121|
|||||506,392|
|||||506,392|
|||||506,392|
For the year ended 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
Page 10
## **WILLIAMS SYNDROME FOUNDATION**
## **BALANCE SHEET** _**AS AT 31 MARCH 2023**_
The financial statements were approved by the Board of Trustees on 6 July 2023 and signed on the board's behalf by:
**P R Lawrie J R Folliss Trustee Trustee**
**Company registration no: 1523794**
Page 11
## **WILLIAMS SYNDROME FOUNDATION**
## **NOTES TO THE FINANCIAL STATEMENTS** _**FOR THE YEAR ENDED 31 MARCH 2023**_
## **1 Status**
Williams Syndrome Foundation is a charitable company limited by guarantee incorporated in England and Wales. The address of the registered office is North House, 198 High Street, Tonbridge Kent, TN9 1BE.
## **2 Accounting policies**
## **2.1 Basis of preparation of accounts**
The financial statements have been prepared in accordance with "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.
Williams Syndrome Foundation meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy note(s).
The financial statements are presented in pounds sterling and rounded to the nearest pound.
There are no material uncertainties about the charity's ability to continue and the going concern basis of accounting continues to be adopted.
## **2.2 Income**
Income from donations is recognised when the charity is entitled to the funds, the receipt is probable and the amount can be measured reliably. For donations this is usually on receipt.
Income from regional conferences is recognised in the period the conference is held. Holiday income is recognised in the period in which the holiday is due to take place. Subscription income is recognised over the period to which it relates. Income received in advance is treated as deferred income.
Income from other trading activities is recognised when receivable on the basis of when the fundraising activities take place.
Income from investments is recognised when receivable.
Page 12
**NOTES TO THE FINANCIAL STATEMENTS** _**FOR THE YEAR ENDED 31 MARCH 2023**_
## **WILLIAMS SYNDROME FOUNDATION**
## **2 Accounting policies (continued)**
## **2.3 Expenditure**
Expenditure is recognised when a present legal or constructive obligation exists at the balance sheet date as a result of a past event, it is probable that a transfer of economic benefits will be required to settle the obligation, and the amount can be measured or estimated reliably. Expenditure is shown inclusive of VAT.
Expenditure, which is charged on an accruals basis, is allocated between:
Expenditure on raising funds which includes costs associated with attracting donations, the cost of purchases for resale and investment management fees.
Expenditure on charitable activities which includes expenditure on the provision of subsidised holidays, medical and research fees and educational activities.
The charity makes research grants on the recommendation of its Professional Advisory Panel. These grants are considered performance related and so are recognised only to the extent that the project has been completed. Where material, grants authorised but not yet paid because they are dependent on future research projects being undertaken, are shown as financial commitments.
All costs are allocated between expenditure activities on a basis designed to reflect the use of the resource. Costs relating to a particular activity are allocated directly. Support costs include the central functions and have been allocated to activities on a basis of time spent on those activities. Governance costs include those costs incurred by the charity in meeting its constitutional and statutory requirements.
## **2.4 Fixed Assets**
Tangible fixed assets are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of fixed assets, less their estimated realisable value, over their expected useful lives, as follows:
Office equipment 33% on cost
During the year the trustees agreed to change the depreciation rate from 25% to 33% on cost as this better reflects the assets useful economic life. As this is a change in estimate this change has been made prospectively.
## **2.5 Investments**
Investments are recognised initially at cost, and then subsequently at their fair value at the balance sheet date, using the quoted market price. Changes in fair value are included in the statement of financial activities under net gains/(losses) on investments.
Page 13
**NOTES TO THE FINANCIAL STATEMENTS** _**FOR THE YEAR ENDED 31 MARCH 2023**_
## **WILLIAMS SYNDROME FOUNDATION**
## **2 Accounting policies (continued)**
## **2.6 Financial instruments**
The charity only has financial instruments of a kind that qualify as basic financial instruments. Shortterm debtors and creditors are measured at settlement value. Any losses from impairment are recognised in income and expenditure.
## **2.7 Fund accounting**
Unrestricted funds are available for use at the discretion of the trustees in furtherance of the general objectives of the charity.
Restricted funds are to be used for specific purposes as laid down by the donor. Expenditure which meets the criteria is allocated to the fund.
|**3**
**Income from donations**
Donations and gifts
Gift Aid
**4**
**Income from charitable activities**
Convention contributions
Holiday income
Subscription income
**5**
**Income from other trading activities**
Income from sales of Christmas cards/publications
In the previous year restricted donations of £11,328 were received.|**2023**
**£**
106,874
15,477
122,351
**2023**
**£**
28,700
5,150
9,726
43,576
**2023**
**£**
10,302
10,302|**2022**
**£**
119,607
11,186|
|---|---|---|
|||130,793|
|||**2022**
**£**
**-**
1,300
9,980|
|||11,280|
|||**2022**
**£**
6,303|
|||6,303|
Page 14
## **WILLIAMS SYNDROME FOUNDATION**
## **NOTES TO THE FINANCIAL STATEMENTS** _**FOR THE YEAR ENDED 31 MARCH 2023**_
|**6**
**Income from investments**
Listed investments
Bank deposits
**7**
**Expenditure on raising funds**
Cost of sales of Christmas cards/publications
Investment portfolio management fees
Staff costs
Allocated support costs (note 9)
**8**
**Expenditure on charitable activities**
**2023**
**2023**
**Direct costs**
**Staff costs**
**£**
**£**
Holiday costs
34,860
734
Medical and research
fees
8,154
882
Publications and
conference
136,431
7,196
Conference
-
6,250
Members events and
family support
22,056
20,539
Admin Support
-
-
201,501
35,601|**2023**
**Support**
**costs**
**£**
354
425
3,467
3,012
9,897
21,607
38,762|**2023**
**£**
11,671
232
11,903
**2023**
**£**
5,440
3,444
6,826
3,289
18,999
**2023**
**Total**
**£**
35,948
9,461
147,094
9,262
52,492
21,607
275,864|**2022**
**£**
10,123
13|
|---|---|---|---|
||||10,136|
||||**2022**
**£**
2,417
3,857
6,834
2,466|
||||15,574|
||||**2022**
**Total**
**£**
21,540
22,044
14,295
7,952
25,378
19,001|
||||110,210|
Expenditure on charitable activities in the comparative period included restricted expenditure of £11,537.
Page 15
## **WILLIAMS SYNDROME FOUNDATION**
## **NOTES TO THE FINANCIAL STATEMENTS** _**FOR THE YEAR ENDED 31 MARCH 2023**_
|**9**
**Support costs**
Staff costs
Insurance
Rent
Bank charges
Printing, postage and stationery
Fees and subscriptions
Payroll fees
Office expenses
Travel expenses
Depreciation of office equipment
Governance costs:
Trustees' expenses
Examiners' remuneration
_Allocated as follows:_
Expenditure on raising funds
Expenditure on charitable activities|**2023**
**£**
21,607
1,467
1,329
809
3,239
1,002
834
6,988
868
560
866
2,482
42,051
3,289
38,762
42,051|**2022**
**£**
19,001
1,509
1,405
755
3,124
387
816
3,802
-
504
301
1,356|
|---|---|---|
|||32,960|
|||2,466
30,494|
|||32,960|
Page 16
## **WILLIAMS SYNDROME FOUNDATION**
## **NOTES TO THE FINANCIAL STATEMENTS** _**FOR THE YEAR ENDED 31 MARCH 2023**_
|**10**
**Staff costs**
Staff costs during the year were as follows:
Wages and salaries
Pension costs|**2023**
**£**
62,179
1,855
64,034|**2022**
**£**
56,017
1,674|
|---|---|---|
|||57,691|
The average number of paid employees during the year was 5 (2022: 4).
No member of staff earned over £60,000 for the financial year (2022: Nil).
Key management personnel are considered to be the trustees and the Chief Executive. Total remuneration of key management personnel, including employers' national insurance and pension contributions, was £27,453 (2022: £23,252). The Trustees did not receive any remuneration during the year. During the year the charity reimbursed 4 trustees £866 (2022: 1 trustee £301) for expenses relating to travel costs.
|**11**|**Net income**|**2023**|**2022**|
|---|---|---|---|
|||**£**|**£**|
||This is stated after charging:|||
||Depreciation|560|504|
||Independent examiners' remuneration|2,482|1,356|
||Independent examiners' remuneration - for other services|834|816|
Page 17
## **WILLIAMS SYNDROME FOUNDATION**
## **NOTES TO THE FINANCIAL STATEMENTS** _**FOR THE YEAR ENDED 31 MARCH 2023**_
|**12**
**Tangible fixed assets**
**Cost**
At 1 April 2022
Additions
Disposals
At 31 March 2023
**Depreciation**
At 1 April 2022
Charge for the year
Disposals
At 31 March 2023
**Net book value at 31 March 2023**
**Net book value at 31 March 2022**
**13**
**Fixed asset investments**
_UK listed investments:_
Market value at 1 April 2022
Additions at cost
Disposals at carrying value
Unrealised (losses) / gains
Market value at 31 March 2023
_Cash held for investment purposes_|**2023**
**£**
397,101
108,482
( 142,205)
( 23,915)
339,463
6,177
345,640|**Office**
**equipment**
**£**
1,618
1,179
( 1,118)|
|---|---|---|
|||1,679|
|||811
560
( 686)|
|||685|
|||994|
|||807|
|||**2022**
**£**
343,121
102,590
( 54,814)
6,204|
|||397,101
12,363|
|||409,464|
Listed investments are stated at their mid market value as at the balance sheet date. Included within disposals are realised losses of £8,119.
Page 18
## **WILLIAMS SYNDROME FOUNDATION**
## **NOTES TO THE FINANCIAL STATEMENTS** _**FOR THE YEAR ENDED 31 MARCH 2023**_
|**14**
**Debtors**
Other debtors and prepayments
**15**
Taxation and social security
Accruals
Deferred income
**Deferred income:**
Income deferred from the previous year
Released to the statement of financial activities
_Arising during the current year_
On holidays
On subscription income
**Creditors: amounts falling due within one year**|**2023**
**£**
3,910
**2023**
**£**
542
16,257
10,090
26,889
35,898
( 35,898)
2,400
7,690
10,090|**2022**
**£**
16,210|
|---|---|---|
|||**2022**
**£**
419
15,661
35,898|
|||51,978|
|||8,563
( 8,563)
28,735
7,163|
|||35,898|
Deferred income relates to amounts received in advance for the holiday due to take place in Summer 2023 and also subscription income received in advance.
Page 19
**WILLIAMS SYNDROME FOUNDATION**
**NOTES TO THE FINANCIAL STATEMENTS** _**FOR THE YEAR ENDED 31 MARCH 2023**_
## **16 Contingent liability**
The charity is committed to further Medical Research grants totalling £1,910 (2022: £2,426). These are not recognised as liabilities as they are subject to performance related conditions which at the balance sheet date had not been fulfilled.
## **17 Funds**
|**_Current year_**
Unrestricted funds
Restricted funds|**Brought**
**forward**
**£**
506,392
-
506,392|**Income**
**£**
185,382
2,750
188,132|**Expenditure**
**and gains/**
**(losses)**
**£**
( 324,147)
( 2,750)
( 326,897)|**Transfers**
**£**
-
-
-|**Carried**
**forward**
**£**
367,627
-|
|---|---|---|---|---|---|
||||||367,627|
During the year, one restricted grant was received. £2,750 was received from The Wood Foundation to support families from North Eastern Scotland. The grant has been fully expensed in the year.
|**_Prior year_**
Unrestricted funds
Restricted funds|**Brought**
**forward**
**£**
457,176
-
457,176|**Income**
**£**
146,975
11,537
158,512|**Expenditure**
**and gains/**
**(losses)**
**£**
( 97,759)
( 11,537)
( 109,296)|**Transfers**
**£**
-
-
-|**Carried**
**forward**
**£**
506,392
-|
|---|---|---|---|---|---|
||||||506,392|
In 2022 two restricted grants were received. £6,537 was received in relation to specific projects for EHCP Clinic services and £5,000 was received to help subsidise staff costs. Both grants were fully expensed in 2022.
Page 20
## **WILLIAMS SYNDROME FOUNDATION**
## **NOTES TO THE FINANCIAL STATEMENTS** _**FOR THE YEAR ENDED 31 MARCH 2023**_
## **18 Analysis of net assets between funds**
|**Analysis of net assets between funds**||||
|---|---|---|---|
|Fixed assets
Net current assets|**Restricted**
**Unrestricted**
**funds**
**funds**
**£**
**£**
-
346,634
-
20,993
-
367,627|**Total**
**funds**
**2023**
**£**
346,634
20,993
367,627|**Total**
**funds**
**2022**
**£**
410,271
96,121|
||||506,392|
## **19 Related party transactions**
There were no related party transactions in the year (2022: £nil).
Page 21